@misc{indiciae1a5629339380,
  title = {Medulloblastoma oncogene aberrations are not involved in tumor initiation, but essential for disease progression and therapy resistance},
  author = {Okonechnikov, K. and Joshi, P. and Koerber, V. and Rademacher, A. and Bortolomeazzi, M. and Mallm, J.-P. and da Silva, P. B. G. and Statz, B. and Sepp, M. and Sarropoulos, I. and Yamada-Saito, T. and Vaillant, J. and Wittmann, A. and Schramm, K. and Blattner-Johnson, M. and Fiesel, P. and Jones, B. and Milde, T. and Pajtler, K. and van Tilburg, C. M. and Witt, O. and Bochennek, K. and Weber, K. J. and Nonnenmacher, L. and Reimann, C. and Schueller, U. and Mynarek, M. and Rutkowski, S. and Jones, D. T. W. and Korshunov, A. and Rippe, K. and Westermann, F. and Thongjuea, S. and Hoefer, T. and Kaessmann, H. and Kutscher, L. M. and Pfister, S. M.},
  year = {2024},
  doi = {10.1101/2024.02.09.579690},
  url = {https://www.biorxiv.org/content/10.1101/2024.02.09.579690v1},
  note = {Source identifier: 10.1101/2024.02.09.579690}
}